https://www.nbcnews.com/health/rcna341257
AI GENERATED
"Mixed Results, but "Real" Impact
You may hear critics say the trials "failed" their primary goal (the "Stage Shift" endpoint). However, the detailed data released in February and April 2026 shows something very important:
The "Stage 4" Win: The tests showed a substantial reduction in Stage 4 diagnoses.
Catching the "Silent Killers": The tests are successfully finding cancers like pancreatic, ovarian, and esophageal—which currently have no other screening methods—at Stage 1 or 2 when they can still be cured..."